期刊文献+

Analysis and determination of diterpenoids in unprocessed and processed Euphorbia lathyris seeds by HPLC-ESI-MS 被引量:4

Analysis and determination of diterpenoids in unprocessed and processed Euphorbia lathyris seeds by HPLC-ESI-MS
下载PDF
导出
摘要 Euphorbia lathyris (Caper spurge) is a toxic and potent Chinese materia medica (T/PCMM). This study sought a method for identifying five diterpenoids (Euphorbia factors LI-L3, L7a, and Ls) with the spectra of UV and mass, quantifying three diterpenoids L1, L2, and L8 in crude extracts of unprocessed and processed E. lathyris seeds by liquid chromatography/ electrospray ionization mass spectrometry (LC-ESI-MS). The analysis was achieved on an Agilent Eclipse XDB-C18 column (4.6 mm× 150mm i.d., 5 μm) with an isocratic elution with a mobile phase consisting of water and acetonitrile at a flow rate of 0.25 mL/min at column temperature of 30 ℃ and UV detection was set at 272 nm. An ESI source was used with a positive ionization mode. The calibration curve was linear in the ranges of 9.9-79 μg/mL for Euphorbia factor Lb 3.8-30.5μg/mL for Euphorbia factor L2, and 1.0-20.6 μg/mL for Euphorbia factor LB. The average recoveries (n=6) of three diterpenoids were 98.39%, 91.10% and 96.94%, respectively, with RSD of 2.5%, 2.4% and 2.1%, respectively. The contents of the three diterpenoids in processed E. lathyris seeds were 3.435, 1.367 and 0.286 mg/g, respectively, which decreased more sharply than those in unprocessed E. lathyris seeds which were 4.915, 1.944 and 0.425 mg/g, respectively. The method is simple, accurate, reliable and reproducible, and it can be applied to control the quality of unprocessed and processed E. lathyris seeds. Euphorbia lathyris (Caper spurge) is a toxic and potent Chinese materia medica (T/PCMM). This study sought a method for identifying five diterpenoids (Euphorbia factors LI-L3, L7a, and Ls) with the spectra of UV and mass, quantifying three diterpenoids L1, L2, and L8 in crude extracts of unprocessed and processed E. lathyris seeds by liquid chromatography/ electrospray ionization mass spectrometry (LC-ESI-MS). The analysis was achieved on an Agilent Eclipse XDB-C18 column (4.6 mm× 150mm i.d., 5 μm) with an isocratic elution with a mobile phase consisting of water and acetonitrile at a flow rate of 0.25 mL/min at column temperature of 30 ℃ and UV detection was set at 272 nm. An ESI source was used with a positive ionization mode. The calibration curve was linear in the ranges of 9.9-79 μg/mL for Euphorbia factor Lb 3.8-30.5μg/mL for Euphorbia factor L2, and 1.0-20.6 μg/mL for Euphorbia factor LB. The average recoveries (n=6) of three diterpenoids were 98.39%, 91.10% and 96.94%, respectively, with RSD of 2.5%, 2.4% and 2.1%, respectively. The contents of the three diterpenoids in processed E. lathyris seeds were 3.435, 1.367 and 0.286 mg/g, respectively, which decreased more sharply than those in unprocessed E. lathyris seeds which were 4.915, 1.944 and 0.425 mg/g, respectively. The method is simple, accurate, reliable and reproducible, and it can be applied to control the quality of unprocessed and processed E. lathyris seeds.
出处 《Journal of Pharmaceutical Analysis》 SCIE CAS 2011年第3期197-202,共6页 药物分析学报(英文版)
基金 supported by the Natural Science Foundation of Zhejiang Province,China (Y2080137)
关键词 Toxic and potentChinese materia medica(T/PCMM) High-performanceliquid chromatography/electrospray ionizationmass spectrometry(HPLC-ESI-MS) Euphorbia lathyris DITERPENOIDS Toxic and potentChinese materia medica(T/PCMM) High-performanceliquid chromatography/electrospray ionizationmass spectrometry(HPLC-ESI-MS) Euphorbia lathyris Diterpenoids
  • 相关文献

参考文献2

二级参考文献16

  • 1李忌,郑耘,郑荣梁,贾忠健.天然二萜类化合物的抗肿瘤活性[J].肿瘤防治研究,1995,22(5):271-272. 被引量:12
  • 2马金双,吴征镒.中国大戟属的修订[J].云南植物研究,1995,17(3):291-295. 被引量:3
  • 3[1]Nishioka Y, Yoshino H. Lymphatic targeting with nanoparticulatesystem [J]. AdvDrug Del Rev, 2001,47:55-64.
  • 4[2]Jacobs C, Kayser O, Müller R H. Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide [J]. Int J Pharm, 2000,196:161-164.
  • 5[3]Liversidege G C, Cundy K C . Particle size reduction for im provement of oral bioavailability of hydrophobic drugs. I. Absolute oral bioavailability of nanocrystalline danazole in beagle dogs [J]. Int JPharm, 1995,127:91-97.
  • 6[4]Duchene D, Ponchel G. Bioadhesion of solid oral dosage forms, why and how [J]. Eur J Pharm Biopharm, 1997,44:15-23.
  • 7[5]Pimienta C, Chouinard F, Labib A, et al. Effects of various poloxamer coatings on in vitro adhesion of isohexylcyanoacrylate nanospheres to rat ileal segments under liquid flow [J]. Int J Pharm, 1992,80:1-8.
  • 8[6]Takeuchi H, Yamamoto H, Niwa T, et al. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes [J]. Pharm Res, 1996,13:896-901.
  • 9[7]Blunk T, Mak E, Müiler R H. Characterization of colloidal drug carriers: determination of surface hydrophobicity by hy drophobic interaction chromatography [J]. Pharm Ind,1993,55:612-615.
  • 10[8]Blunk T, Lück M, Calvor A, et al. Kinetics of plasma protein adsorption on model particles for controlled drug delivery and drug targeting [J]. Eur J Pharm Biopharm, 1996, 42:262-268.

共引文献60

同被引文献62

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部